Cause of death, by non-communicable diseases, ages 15-59 in Tajikistan
Tajikistan: Cause of death, by non-communicable diseases, ages 15-59 was 51.5% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 15-59 in Tajikistan, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 15-59.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 15-59 in Tajikistan stood at 51.5%.
The figure is up 12.9% on the previous year and down 20.9% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59 in Tajikistan peaked at 67.7% in 2019 and was at its lowest, 45.6%, in 2020.
Tajikistan ranks 103rd of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59 in Tajikistan, year by year
| Year | % of total deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 61.8% | — |
| 2010 | 65.1% | +5.4% |
| 2015 | 67.3% | +3.5% |
| 2019 | 67.7% | +0.5% |
| 2020 | 45.6% | -32.7% |
| 2021 | 51.5% | +12.9% |
Tajikistan compared with similar countries
- Tajikistan's 51.5% is above the median for lower middle income countries, which is 46.3%, 1.1× the median. (47 countries reporting)
- Tajikistan's 51.5% is below the median for Europe & Central Asia, which is 68.4%, 75% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 61.8% | 61.8% | 61.8% | 1 |
| 2010s | 66.7% | 65.1% | 67.7% | 3 |
| 2020s | 48.5% | 45.6% | 51.5% | 2 |
Countries ranked near Tajikistan
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,061 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.6758 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0596 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.6416 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59 in Tajikistan?
- Cause of death, by non-communicable diseases, ages 15-59 in Tajikistan was 51.5% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59 recorded in Tajikistan?
- The highest recorded value was 67.7% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59 recorded in Tajikistan?
- The lowest recorded value was 45.6% in 2020.
- How does Tajikistan rank for cause of death, by non-communicable diseases, ages 15-59?
- Tajikistan ranks 103rd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59 rising or falling in Tajikistan?
- Over the last ten years it is down 20.9%. The long-run trend across the full record is falling.
- Where does this Tajikistan data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.